Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincristine Sulfate Liposome vs Vincristine Sulfate in Adult ALL
NCT02072785Phase 3Unknown
- Sponsor
- Luye Pharma Group
- Start
- Jun 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of vincristine sulfate liposome in acute lymphoblastic leukemia (ALL), sponsored by Luye Pharma Group. Status: unknown.
02
Drugs
vincristine sulfate liposome
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02072785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02072785.